Ìý
Dr. Lorenzo Ferri'sÌýResearch Laboratory
We are committed to enhancing treatment outcomes for gastric and esophageal cancers, as well as delving into the fundamental mechanisms driving resistance to neoadjuvant/adjuvant therapy.
Ìý
Ìý
Dr. Jonathan Spicer's Research Laboratory
Our group's main focus is to unravel the molecular mechanisms behind NET/CTC interactions and determine if tumor-bearing individuals are predisposed to NET formation, which might hold prognostic significance.
Ìý
Ìý
Ìý
Dr. Sara Najmeh's Research Laboratory
Our team conducts innovative research aimed at improving patient outcomes, enhancing medical knowledge, and ultimately, shaping the future of healthcare.Ìý
​â¶Ä‹â¶Ä‹â¶Ä‹Read My PublicationsÌý
Ìý
Dr. Jonathan Cools's Research Laboratory
Our central research objective is to understand the ways in which neutrophils influence tumor progression and systemic inflammation in gastrointestinal and esophageal cancers (GEA).
Ìý
Ìý
Dr. Swneke Bailey's Research LaboratoryÌý
We concentrate on deciphering the influence of coding and non-coding somatic mutations, as well as changes in the chromatin landscape, in the journey of these cancers toward metastasis and more.
Ìý
Shaping the Future of Healthcare: Meet the Distinguished Researcher Dr. Carmen Mueller
Dr. Mueller’s research program comprises two main focuses: surgical education and surgical outcomes. Current and previous projects include determining the needs, barriers to and outcomes of peer coaching for continuous skills improvement among surgeons in practice, and evaluating surgical techniques, enhance recovery program implementation, and quality improvement projects in the enhancement of patient outcomes after benign and malignant upper gastrointestinal surgery. Dr. Mueller has supervised numerous trainees including Master’s and PhD students, as well as fellows, residents and medical students. She has published >60 peer reviewed primary research papers, coauthored numerous book chapters and regularly invited to speak as an expert in her field and national and international conferences and is the recipient of the highly competitive Fonds de recherche du Quebec - sante (FRQS) clinician scientist award in 2021.
Ìý
Catalysts of Change: Dr. Trafford Crump's Transformative Research
Our lab is committed to enhancing surgical oncology care by developing innovative approaches to measuring and incorporating patient preferences, experiences, and outcomes, with a particular focus on transforming how decisions are made and success is measured in thoracic surgery.
Dr. Crump, who holds the Jarislowsky Foundation Chair in Thoracic Surgery, leads this multidisciplinary research program at the intersection of surgical outcomes and patient-centered care.
Ìý
Dr. Dae-Kyum Kim'sÌýResearch Laboratory
Throughout my career, I have focused on the generation and integration of high-throughput data to propose novel hypotheses for experimental validation or new clinical biomarkers.ÌýIn the Kim lab at Roswell Park Comprehensive Cancer Center, we have a broad research interest in developing and utilizing novel platforms to generate various omics data to solve clinical problems, such as drug resistance in cancer chemotherapy.
Ìý
Ìý
Ìý
Ìý